scholarly journals Whole-body hyperthermia-induced thermotolerance is associated with the induction of Heat Shock Protein 70 in mice

2002 ◽  
Vol 205 (2) ◽  
pp. 273-278
Author(s):  
Yueh-Tsu King ◽  
Chih-Sheng Lin ◽  
Jyh-Hung Lin ◽  
Wen-Chuan Lee

SUMMARY Molecular mechanisms of whole-body thermotolerance (WBT) in mammals have not been investigated thoroughly. The purpose of this study was to assess the induction of the 70 kDa heat shock protein (HSP70) and antioxidant enzyme activity in animal WBT, which was induced by whole-body hyperthermia (WBH) in mice. As a preconditioning treatment, WBH was applied to mice to induce WBT. Synthesis of inducible HSP70 (HSP70i) and quantification of its increased level in liver were investigated by one- and two-dimensional polyacrylamide gel electrophoresis and immunoblotting. HSP70i synthesis in mice liver was induced by non-lethal WBH (41°C, 30 min). When compared to control animals, the level of liver HSP70i increased substantially (by 3.6-fold; P<0.0001). When exposed to 30 min of hyperthermia preconditioning, and after recovery for 48 h, the survival rate was 88.2 %, which was significantly higher than that of the control group (37.5 %; P<0.01). Moreover, the survival rate of animals subjected to preconditioning for 15 min was 72.2 %, which was also significantly higher than that of the control group (P<0.05). In contrast, the survival rate of animals subjected to preconditioning for 45 min was 63.5 %, which was not different from the control group. Nonetheless, the protection index of the group subjected to 15 min and 30 min of preconditioning was 1.93 and 2.37, respectively. Furthermore, to assess their contributions to WBT, the activities of antioxidant enzymes were also measured. After 48 h of recovery in preconditioned animals, hepatic antioxidant enzyme activities, including superoxide dismutase, catalase and glutathione peroxidase, had not changed significantly. To study the molecular mechanism of WBT, we successfully developed a mouse model and suggest that, rather than the activities of antioxidant enzymes, it is HSP70i that has a role to help animals survive during severe heat stress.

1999 ◽  
Vol 22 (1) ◽  
pp. 67-70 ◽  
Author(s):  
D??rthe M. Katschinski ◽  
Rainer Benndorf ◽  
G??nter J. Wiedemann ◽  
Daniel L. Mulkerin ◽  
Reza Touhidi ◽  
...  

2019 ◽  
Vol 89 (3-4) ◽  
pp. 161-167 ◽  
Author(s):  
Reza Mahdavi ◽  
Tannaz khabbazi ◽  
Javid Safa

Abstract. Background: Cardiovascular disease (CVD) is the main cause of death in hemodialysis (HD) patients and oxidative stress is an important risk factor for CVD. Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) are primary antioxidant enzymes in human cells acting against toxic reactive oxygen species (ROS) and their reduced activity may contribute to oxidative disorders in HD patients. Alpha lipoic acid (ALA) as a potent strong antioxidant may affect these enzymes. Objective: We examined the effects of ALA supplementation on antioxidant enzyme activities in HD patients. Method: In this double-blinded, randomized clinical trial, 63 HD patients (43 males and 20 females; age range: 22–79 years) were assigned into the ALA group (n: 31), receiving a daily dose of ALA (600 mg), or a control group (n: 32), receiving placebo for 8 weeks. Body mass index (BMI), antioxidant enzymes, albumin (Alb) and hemoglobin (Hb) were determined before and after intervention. Results: At baseline, the mean blood activities of SOD, GPx, and CAT in ALA group were 1032±366, 18.9±5.09 and 191±82.7 U/gHb which increased at the end of study to 1149±502, 19.1±7.19 and 208±86.6 U/gHb respectively. However, only the increase of SOD was statistically significant in comparison with placebo group (P = 0.04). The mean levels of Alb, Hb, weight and BMI were not significantly changed in study groups (P>0.05). Conclusion: ALA may be beneficial for HD patients by increasing the activity of antioxidant enzymes; however, further studies are needed to achieve precise results.


2005 ◽  
Vol 30 (7) ◽  
pp. 511-517 ◽  
Author(s):  
Yana V. Malyutina ◽  
Yulia M. Makarova ◽  
Tamara N. Semenets ◽  
Olga V. Semina ◽  
Alexei F. Mosin ◽  
...  

1991 ◽  
Vol 17 (2) ◽  
pp. A132
Author(s):  
Thomas J Donnelly ◽  
Richard E Sievers ◽  
William J Welch ◽  
Frank Visseren ◽  
M.Andrew Levitt ◽  
...  

2014 ◽  
Vol 30 (8) ◽  
pp. 540-546 ◽  
Author(s):  
Jason W.-L. Eng ◽  
Chelsey B. Reed ◽  
Kathleen M. Kokolus ◽  
Elizabeth A. Repasky

1998 ◽  
Vol 258 (3) ◽  
pp. 151-154 ◽  
Author(s):  
Hong Xia ◽  
Takaaki Ikata ◽  
Shinsuke Katoh ◽  
Kazuhito Rokutan ◽  
Shin-ichiro Saito ◽  
...  

1990 ◽  
Vol 52 ◽  
pp. 146
Author(s):  
Midori Hirai ◽  
Katsuhiko Okumura ◽  
Naoaki Saitoh ◽  
Takayoshi Kuno ◽  
Chikako Tanaka

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Jonna Weisell ◽  
Pauli Ohukainen ◽  
Juha Näpänkangas ◽  
Steffen Ohlmeier ◽  
Ulrich Bergmann ◽  
...  

Abstract Background Calcific aortic valve disease (CAVD) is an atheroinflammatory process; finally it leads to progressive calcification of the valve. There is no effective pharmacological treatment for CAVD and many of the underlying molecular mechanisms remain unknown. We conducted a proteomic study to reveal novel factors associated with CAVD. Methods We compared aortic valves from patients undergoing valvular replacement surgery due to non-calcified aortic insufficiency (control group, n = 5) to a stenotic group (n = 7) using two-dimensional difference gel electrophoresis (2D-DIGE). Protein spots were identified with mass spectrometry. Western blot and immunohistochemistry were used to validate the results in a separate patient cohort and Ingenuity Pathway Analysis (IPA) was exploited to predict the regulatory network of CAVD. Results We detected an upregulation of complement 9 (C9), serum amyloid P-component (APCS) and transgelin as well as downregulation of heat shock protein (HSP90), protein disulfide isomerase A3 (PDIA3), annexin A2 (ANXA2) and galectin-1 in patients with aortic valve stenosis. The decreased protein expression of HSP90 was confirmed with Western blot. Conclusions We describe here a novel data set of proteomic changes associated with CAVD, including downregulation of the pro-inflammatory cytosolic protein, HSP90.


Sign in / Sign up

Export Citation Format

Share Document